Using genome and transcriptome data from African-ancestry female participants to identify putative breast cancer susceptibility genes
-
Published:2024-05-02
Issue:1
Volume:15
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Ping JieORCID, Jia GuochongORCID, Cai QiuyinORCID, Guo XingyiORCID, Tao Ran, Ambrosone ChristineORCID, Huo DezhengORCID, Ambs StefanORCID, Barnard Mollie E., Chen Yu, Garcia-Closas MontserratORCID, Gu JianORCID, Hu Jennifer J.ORCID, John Esther M., Li Christopher I., Nathanson KatherineORCID, Nemesure Barbara, Olopade Olufunmilayo I., Pal Tuya, Press Michael F.ORCID, Sanderson Maureen, Sandler Dale P.ORCID, Yoshimatsu Toshio, Adejumo Prisca O., Ahearn ThomasORCID, Brewster Abenaa M., Hennis Anselm J. M., Makumbi Timothy, Ndom Paul, O’Brien Katie M., Olshan Andrew F., Oluwasanu Mojisola M., Reid Sonya, Yao SongORCID, Butler Ebonee N.ORCID, Huang Maosheng, Ntekim AtaraORCID, Li BingshanORCID, Troester Melissa A., Palmer Julie R., Haiman Christopher A.ORCID, Long Jirong, Zheng WeiORCID
Abstract
AbstractAfrican-ancestry (AA) participants are underrepresented in genetics research. Here, we conducted a transcriptome-wide association study (TWAS) in AA female participants to identify putative breast cancer susceptibility genes. We built genetic models to predict levels of gene expression, exon junction, and 3′ UTR alternative polyadenylation using genomic and transcriptomic data generated in normal breast tissues from 150 AA participants and then used these models to perform association analyses using genomic data from 18,034 cases and 22,104 controls. At Bonferroni-corrected P < 0.05, we identified six genes associated with breast cancer risk, including four genes not previously reported (CTD-3080P12.3, EN1, LINC01956 and NUP210L). Most of these genes showed a stronger association with risk of estrogen-receptor (ER) negative or triple-negative than ER-positive breast cancer. We also replicated the associations with 29 genes reported in previous TWAS at P < 0.05 (one-sided), providing further support for an association of these genes with breast cancer risk. Our study sheds new light on the genetic basis of breast cancer and highlights the value of conducting research in AA populations.
Funder
U.S. Department of Health & Human Services | National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021). 2. DeSantis, C. E. et al. Breast cancer statistics, 2019. CA Cancer J. Clin. 69, 438–451 (2019). 3. Jatoi, I., Sung, H. & Jemal, A. The emergence of the racial disparity in U.S. breast-cancer mortality. N. Engl. J. Med. 386, 2349–2352 (2022). 4. Newman, L. A. & Kaljee, L. M. Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg. 152, 485–493 (2017). 5. Dignam, J. J. Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J. Clin. 50, 50–64 (2000).
|
|